Aspen Pharmacare Holdings Ltd (APN) - Total Assets
Based on the latest financial reports, Aspen Pharmacare Holdings Ltd (APN) holds total assets worth ZAC135.89 Billion ZAC (≈ $72.22 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore how well can Aspen Pharmacare Holdings Ltd service its debt to assess how comfortably operating cash covers total debt obligations.
Aspen Pharmacare Holdings Ltd - Total Assets Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's total assets have evolved over time, based on quarterly financial data. See Aspen Pharmacare Holdings Ltd (APN) shareholders funds for net asset value and shareholders' equity analysis.
Aspen Pharmacare Holdings Ltd - Asset Composition Analysis
Current Asset Composition (June 2025)
Aspen Pharmacare Holdings Ltd's total assets of ZAC135.89 Billion consist of 28.5% current assets and 71.5% non-current assets.
| Asset Category | Amount (ZAC) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ZAC0.00 | 4.7% |
| Accounts Receivable | ZAC13.34 Billion | 9.8% |
| Inventory | ZAC18.01 Billion | 13.3% |
| Property, Plant & Equipment | ZAC0.00 | 0.0% |
| Intangible Assets | ZAC67.21 Billion | 49.5% |
| Goodwill | ZAC5.20 Billion | 3.8% |
Asset Composition Trend (2003–2025)
This chart illustrates how Aspen Pharmacare Holdings Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see APN market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Aspen Pharmacare Holdings Ltd's current assets represent 28.5% of total assets in 2025, a decrease from 49.2% in 2003.
- Cash Position: Cash and equivalents constituted 4.7% of total assets in 2025, down from 11.9% in 2003.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 52.0% of total assets, an increase from 29.0% in 2003.
- Asset Diversification: The largest asset category is intangible assets at 49.5% of total assets.
Aspen Pharmacare Holdings Ltd Competitors by Total Assets
Key competitors of Aspen Pharmacare Holdings Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Jiangsu Hengrui Medicine Co Ltd
SHG:600276
|
China | CN¥68.33 Billion |
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2
|
Germany | €1.60 Trillion |
|
Ajanta Pharma Limited
NSE:AJANTPHARM
|
India | Rs56.72 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.84 Billion |
|
Tianjin Zhongxin Pharmaceutical Group Corp Ltd
SHG:600329
|
China | CN¥11.59 Billion |
|
Tianjin Ringpu Bio Tech
SHE:300119
|
China | CN¥7.80 Billion |
|
Zhejiang Tianyu Pharmaceutical Co Ltd
SHE:300702
|
China | CN¥6.56 Billion |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557
|
China | CN¥6.74 Billion |
Aspen Pharmacare Holdings Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.21 | 1.81 | 2.03 |
| Quick Ratio | 1.18 | 1.07 | 1.12 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ZAC21.21 Billion | ZAC19.71 Billion | ZAC18.66 Billion |
Aspen Pharmacare Holdings Ltd - Advanced Valuation Insights
This section examines the relationship between Aspen Pharmacare Holdings Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.59 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | -2.3% |
| Total Assets | ZAC135.89 Billion |
| Market Capitalization | $3.59 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Aspen Pharmacare Holdings Ltd's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Aspen Pharmacare Holdings Ltd's assets decreased by 2.3% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Aspen Pharmacare Holdings Ltd (2003–2025)
The table below shows the annual total assets of Aspen Pharmacare Holdings Ltd from 2003 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-06-30 | ZAC135.89 Billion ≈ $72.22 Million |
-2.34% |
| 2024-06-30 | ZAC139.16 Billion ≈ $73.95 Million |
+3.63% |
| 2023-06-30 | ZAC134.28 Billion ≈ $71.37 Million |
+20.57% |
| 2022-06-30 | ZAC111.38 Billion ≈ $59.19 Million |
+1.54% |
| 2021-06-30 | ZAC109.68 Billion ≈ $58.29 Million |
-17.64% |
| 2020-06-30 | ZAC133.17 Billion ≈ $70.77 Million |
+8.87% |
| 2019-06-30 | ZAC122.32 Billion ≈ $65.00 Million |
-7.92% |
| 2018-06-30 | ZAC132.84 Billion ≈ $70.60 Million |
+14.22% |
| 2017-06-30 | ZAC116.30 Billion ≈ $61.81 Million |
+11.51% |
| 2016-06-30 | ZAC104.30 Billion ≈ $55.43 Million |
+17.96% |
| 2015-06-30 | ZAC88.42 Billion ≈ $46.99 Million |
+7.11% |
| 2014-06-30 | ZAC82.55 Billion ≈ $43.87 Million |
+81.74% |
| 2013-06-30 | ZAC45.42 Billion ≈ $24.14 Million |
+43.20% |
| 2012-06-30 | ZAC31.72 Billion ≈ $16.86 Million |
+18.36% |
| 2011-06-30 | ZAC26.80 Billion ≈ $14.24 Million |
+35.33% |
| 2010-06-30 | ZAC19.80 Billion ≈ $10.52 Million |
+58.13% |
| 2009-06-30 | ZAC12.52 Billion ≈ $6.65 Million |
+15.42% |
| 2008-06-30 | ZAC10.85 Billion ≈ $5.77 Million |
+44.03% |
| 2007-06-30 | ZAC7.53 Billion ≈ $4.00 Million |
+76.42% |
| 2006-06-30 | ZAC4.27 Billion ≈ $2.27 Million |
+36.13% |
| 2005-06-30 | ZAC3.14 Billion ≈ $1.67 Million |
+48.66% |
| 2004-06-30 | ZAC2.11 Billion ≈ $1.12 Million |
+25.45% |
| 2003-06-30 | ZAC1.68 Billion ≈ $893.74K |
-- |
About Aspen Pharmacare Holdings Ltd
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic ag… Read more